Panitumumab
Amgen,Takeda
[]
 waiting for the forthcoming phase 3 to confirm stop&amp;go efficacy of chemotherapy + anti-egfr
MD, PhD. GI Medical Oncologist - Abdominal Medical Oncology Unit - INT Fondazione G. Pascale - Napoli @istitutotumori